These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33928358)

  • 21. Elucidation of the kijanimicin gene cluster: insights into the biosynthesis of spirotetronate antibiotics and nitrosugars.
    Zhang H; White-Phillip JA; Melançon CE; Kwon HJ; Yu WL; Liu HW
    J Am Chem Soc; 2007 Nov; 129(47):14670-83. PubMed ID: 17985890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfamates and their therapeutic potential.
    Winum JY; Scozzafava A; Montero JL; Supuran CT
    Med Res Rev; 2005 Mar; 25(2):186-228. PubMed ID: 15478125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanded natural product diversity revealed by analysis of lanthipeptide-like gene clusters in actinobacteria.
    Zhang Q; Doroghazi JR; Zhao X; Walker MC; van der Donk WA
    Appl Environ Microbiol; 2015 Jul; 81(13):4339-50. PubMed ID: 25888176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aminoglycoside Antibiotics: New Insights into the Biosynthetic Machinery of Old Drugs.
    Kudo F; Eguchi T
    Chem Rec; 2016 Feb; 16(1):4-18. PubMed ID: 26455715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Actinomycetes biosynthetic potential: how to bridge in silico and in vivo?
    Rebets Y; Brötz E; Tokovenko B; Luzhetskyy A
    J Ind Microbiol Biotechnol; 2014 Feb; 41(2):387-402. PubMed ID: 24127068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic biology of secondary metabolite biosynthesis in actinomycetes: Engineering precursor supply as a way to optimize antibiotic production.
    Wohlleben W; Mast Y; Muth G; Röttgen M; Stegmann E; Weber T
    FEBS Lett; 2012 Jul; 586(15):2171-6. PubMed ID: 22710162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulfamates in drug design and discovery: Pre-clinical and clinical investigations.
    Zaraei SO; Abduelkarem AR; Anbar HS; Kobeissi S; Mohammad M; Ossama A; El-Gamal MI
    Eur J Med Chem; 2019 Oct; 179():257-271. PubMed ID: 31255926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural product discovery: past, present, and future.
    Katz L; Baltz RH
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):155-76. PubMed ID: 26739136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome Mining of Amino Group Carrier Protein-Mediated Machinery: Discovery and Biosynthetic Characterization of a Natural Product with Unique Hydrazone Unit.
    Matsuda K; Hasebe F; Shiwa Y; Kanesaki Y; Tomita T; Yoshikawa H; Shin-Ya K; Kuzuyama T; Nishiyama M
    ACS Chem Biol; 2017 Jan; 12(1):124-131. PubMed ID: 28103675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.
    Minakuchi T; Nishimori I; Vullo D; Scozzafava A; Supuran CT
    J Med Chem; 2009 Apr; 52(8):2226-32. PubMed ID: 19317447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From Antibacterial to Antitumour Agents: A Brief Review on The Chemical and Medicinal Aspects of Sulfonamides.
    Azevedo-Barbosa H; Dias DF; Franco LL; Hawkes JA; Carvalho DT
    Mini Rev Med Chem; 2020; 20(19):2052-2066. PubMed ID: 32888265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biosynthesis of C-nucleoside antibiotics in actinobacteria: recent advances and future developments.
    Zhang M; Kong L; Gong R; Iorio M; Donadio S; Deng Z; Sosio M; Chen W
    Microb Cell Fact; 2022 Jan; 21(1):2. PubMed ID: 34983520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Harnessing Rare Actinomycete Interactions and Intrinsic Antimicrobial Resistance Enables Discovery of an Unusual Metabolic Inhibitor.
    McClung DJ; Du Y; Antonich DJ; Bonet B; Zhang W; Traxler MF
    mBio; 2022 Jun; 13(3):e0039322. PubMed ID: 35608300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are There Any Other Compounds Isolated From Dermacoccus spp at All?
    AlMatar M; Eldeeb M; Makky EA; Köksal F; Var I; Kayar B
    Curr Microbiol; 2017 Jan; 74(1):132-144. PubMed ID: 27785553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triggers and cues that activate antibiotic production by actinomycetes.
    Zhu H; Sandiford SK; van Wezel GP
    J Ind Microbiol Biotechnol; 2014 Feb; 41(2):371-86. PubMed ID: 23907251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of N-acylated tyramine sulfamates containing C-F bonds as steroid sulfatase inhibitors.
    Daśko M; Rachon J; Masłyk M; Kubiński K; Demkowicz S
    Chem Biol Drug Des; 2017 Jul; 90(1):156-161. PubMed ID: 28032462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genus
    Shi T; Wang YF; Wang H; Wang B
    Mar Drugs; 2022 May; 20(6):. PubMed ID: 35736177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. QSAR studies of sulfamate and sulfamide inhibitors targeting human carbonic anhydrase isozymes I, II, IX and XII.
    Tarko L; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1404-9. PubMed ID: 23206986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation, biological activity, biosynthesis and synthetic studies towards the rubromycin family of natural products.
    Atkinson DJ; Brimble MA
    Nat Prod Rep; 2015 Jun; 32(6):811-40. PubMed ID: 25798711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unexpected furanose/pyranose equilibration of N-glycosyl sulfonamides, sulfamides and sulfamates.
    Suthagar K; Polson MI; Fairbanks AJ
    Org Biomol Chem; 2015 Jun; 13(23):6573-9. PubMed ID: 25982459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.